CTIS2023-504847-15-00进行中(未招募)1 期
Intranasal Sufentanil for Analgesia of Severe Sickle Cell Vaso-occlusive Pain Crisis in the Pediatric Emergency Department: a Double Blind Randomized versus placebo Controlled Trial (INVOPE) - APHP211035
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中(未招募)
- 入组人数
- 915
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 0 至 17(—)
- 性别
- All
入选标准
- •At inclusion visit •Sickle-cell disease = Hemoglobin SS or SC or Sß-thalassemia •Age < 18 years old •Weight > 10 kgs •Registered with the social security scheme (or State Medical Aid - AME) or his/her beneficiaries •Informed consent of the holder (s) of the exercise of parental authority, At randomization visit •Age < 18 years old •Presenting to the ED with vaso-occlusive crisis: migratory bone pain, which may occur in the limbs, spine, thorax, pelvis, skull; or crisis known as such by the patient. •Severe pain determined at triage, defined as: - EVENDOL = 10/15 in children aged 0-18 years (this pain scale is allowed in children > 8 years only for randomization) or -NRS-11 = 7/10 in children aged 8 years to less than 18 years •Informed consent of the holder (s) of the exercise of parental authority signed at inclusion visit or at randomisation visit
排除标准
- •At inclusion visit •Known cirrhosis •End-stage renal disease requiring kidney dialysis •Known hypersensitivity to sufentanil, any of the excipients or to morphine •Facial malformation, epistaxis, blocked or traumatised nose. •Patient's or parent's refusal to participate •Parents who do not speak French, At randomization visit •Strong opioids received <6 hours (morphine, oxycodone, hydromorphone, fentanyl, sufentanil, nalbuphine) •Respiratory failure (tachypnea; bradypnea; paradoxical breathing; grunting; head-bobbing; nasal flaring; retractions (subcostal, suprasternal, intercostal, sternal)) •Oxygen saturations below 95% on initial assessment •Hemodynamic disorders: tachycardia, hypotension •Altered conscious state as defined by a Glasgow Coma score less than 15 •Patient's or Parent's refusal to participate or withdrawal of parental consent •Patient has already been randomised to the INVOPE trial during a previous VOC •Positive urinary pregnancy test for woman of childbearing potential (postpubertal female with sexual activity), •Participation in another interventional trial
研究者
相似试验
尚未招募
2 期
A study of intranasal remifentanil for intubation and surfactant administration in newbornsPain management for premature infants undergoing intubation.Reproductive Health and Childbirth - Complications of newbornAnaesthesiology - Pain managementACTRN12612000386831Associate Professor Ian Wright40
进行中(未招募)
1 期
Intranasal Sufentanyl analgesia Versus Morphine IV in Emergency room.EUCTR2013-001665-16-FRniversity Hospital Grenoble220
进行中(未招募)
1 期
A trial of intranasal remifentanil for painful ophthalmic procedures.Painful ophthalmic proceduresEUCTR2006-002460-26-GBBHT78
已完成
4 期
Intra Nasal Sufentanil Versus Intravenous Morphine for Acute Severe Traumatic Pain Analgesia in Emergency SettingSevere Traumatic PainNumeric Pain Rating Scale > 5 / 10NCT02095366University Hospital, Grenoble194
进行中(未招募)
不适用
Study where a pain medicine (fentanyl) is administered through nostrils and into nasal cavity by paramedics in an out-of-hospital situations. The efficacy and safety of the medicine is assessed in those situations.Patients with trauma, musculoskeletal, stomach or back pain on numeric rating scale at least value 4EUCTR2014-005286-69-FIKuopion yliopistollinen sairaala/Ensihoitokeskus
